World leading healthcare evidence, pricing and access congress

Alex is Vice President of Commercial Strategy & Market Access at Memo Therapeutics. He is a serial biotech leader that has previously held roles at companies, such as AM-Pharma, Galapagos, and Incyte. He started his career with pharmaceutical heavyweights such as Pfizer and Amgen. He holds an...

Toon Digneffe is Head of Public Affairs & Public Policy at Takeda. He has over 25 years’ experience in government affairs, communications, market access and patient advocacy at local, regional and global level. Mr Digneffe has extensive experience in pharmaceutical industry, as he has been...

Jagpreet Chhatwal is a health economist, decision scientist, and academic leader whose work bridges artificial intelligence, health economics, market access, and public health policy. He is the Director of the Center for Health Technology Assessment at Mass General Brigham and an Associate...

Global pharmaceutical executive with extensive experience in R&D, market access, pricing strategy, evidence generation, Business Development and New Product Planning. Proven track record of launching 20+ innovative medicines and indications since 2018, driving double-digit growth and shaping...

Prof. Dr. Eva Susanne Dietrich has extensive experience in pharmaceutical market access, benefit assessment, reimbursement, and health policy in Germany. She is a pharmacist by training and has worked for more than 25 years at the interface of evidence-based medicine, health economics, statutory...

Ayman Semaan | Market Access & Pricing Lead | Pharma & Life Sciences Expert Ayman Semaan is a Market Access & Pricing Lead with 20 years in the life sciences industry, including over a decade dedicated to pharmaceutical pricing strategy and access policy across the Levant, Gulf, and...

Jiri Smejkal is the International Business Unit Head of Access & Value for Plasma Derived Therapies (PDT), leading global strategy to ensure broad, rapid patient access to innovative treatments across global markets. An executive with over a decade of leadership, GMs' regional roles and...

Yvette Venable Global Payer Partnerships and Policy, AstraZeneca Ms. Venable is an accomplished life sciences leader, with more than 25 years’ experience in health policy and public affairs, patient engagement and advocacy, and market access. Currently, she leads global value and market access...

Reg is currently the Head of Global Market Access at Bayer which includes team members responsible for Market Access, Pricing & Value Optimization and Health Economics & Outcomes Research. He is a biopharma leader with over 25 years experience in Pharma and Biotech in the US, Australia and...

Marieangela Economopoulou is Head of Access & External Engagement for Southeast Europe at UCB, where she leads the development and execution of market access and external affairs strategies across the region. With over 18 years of experience in the pharmaceutical and MedTech...

Gavin originally was an undergraduate in Economics and Politics, before working for the Scottish Government as an Economist in the Health Department. After obtaining an MSc in Health Economics from York University, he joined the Pharmaceutical industry for Roche in the UK where he worked for over...

Michael Andreou is a market access and pricing leader with over 25 years access and commercial strategy experience in pharma and biotech. He has broad therapeutic area experience, especially in rare diseases, and is leading Biogen ex-US access & pricing strategy and execution currently focusing ...

Georges André is a healthcare strategy professional with over 30 years of international experience spanning pharmaceuticals, medical devices, and consulting. He spent a decade in the pharmaceutical industry at UCB and Sanofi, followed by 20 years at Boston Scientific, where he held senior roles...

Marta Słomka is a healthcare professional currently serving as the Deputy Director of the Health Technology Assessment (HTA) Department at the Polish Health Technology Assessment and Tariff System Agency (AOTMiT). In this role, she oversees departmental operations, drives strategic initiatives, and ...